Skip to main content
Top

International Journal of Clinical Oncology

Issue 1/2023

Including Invited Reviews on Cancer among adolescents and young adults in Japan – 3

Content (19 Articles)

Liposarcoma Invited Review Article

Soft-tissue sarcoma in adolescents and young adults

Toshiyuki Kunisada, Eiji Nakata, Tomohiro Fujiwara, Ako Hosono, Shota Takihira, Hiroya Kondo, Toshifumi Ozaki

Open Access Bone Defect Invited Review Article

Joint-preservation surgery for bone sarcoma in adolescents and young adults

Norio Yamamoto, Yoshihiro Araki, Hiroyuki Tsuchiya

Hereditary Syndromes Invited Review Article

Current clinical perspective of urological oncology in the adolescent and young adult generation

Ryohei Takahashi, Hiroshi Asanuma, Ryuichi Mizuno, Mototsugu Oya

Stroke Review Article

Risk of mortality and other adverse outcomes from myocardial infarction in cancer survivors: a meta-analysis

Xu Dongchen, Li Tongyi, Mu Xueping, Shan Jingjing, Li Quanhong

Glioma Original Article

ADAMTS1 as potential prognostic biomarker promotes malignant invasion of glioma

Shanshan Wang, Jin Zhang, Ke Wang, Yuanli Zhao, Dongying Liu

Open Access Lung Cancer Original Article

Identification of risk factors for venous thromboembolism and validation of the Khorana score in patients with advanced lung cancer: based on the multicenter, prospective Rising-VTE/NEJ037 study data

Yukari Tsubata, Keita Kawakado, Kosuke Hamai, Naoki Furuya, Toshihide Yokoyama, Ryota Saito, Atsushi Nakamura, Takeshi Masuda, Megumi Hamaguchi, Shoichi Kuyama, Ryoichi Honda, Tadashi Senoo, Masamoto Nakanishi, Takamasa Hotta, Masahiro Yamasaki, Nobuhisa Ishikawa, Kazunori Fujitaka, Tetsuya Kubota, Kunihiko Kobayashi, Takeshi Isobe

NSCLC Original Article

Overall survival analysis of patients enrolled in a randomized phase III trial comparing gefitinib and erlotinib for previously treated advanced lung adenocarcinoma (WJOG5108LFS)

Nobuyuki Katakami, Toshihide Yokoyama, Satoshi Morita, Tatsuro Okamoto, Yoshiko Urata, Yoshihiro Hattori, Yasuo Iwamoto, Yuki Sato, Norihiko Ikeda, Toshiaki Takahashi, Haruko Daga, Tetsuya Oguri, Yasuhito Fujisaka, Kazumi Nishino, Shunichi Sugawara, Toshiyuki Kozuki, Masahide Oki, Nobuyuki Yamamoto, Kazuhiko Nakagawa

Breast Cancer Original Article

Pre-treatment levels of inflammatory markers and chemotherapy completion rates in patients with early-stage breast cancer

Tim Schauer, Anna Henriksson, Emelie Strandberg, Henrik Lindman, Sveinung Berntsen, Ingrid Demmelmaier, Truls Raastad, Karin Nordin, Jesper F. Christensen

Gastrectomy Original Article

Relative dose intensity and 1-year psoas muscle index reduction rate as prognostic factors in gastric cancer patients with postoperative adjuvant chemotherapy

Shohei Fujita, Shinichi Sakuramoto, Kazuaki Matsui, Gen Ebara, Keiji Nishibeppu, Shuichiro Oya, Shiro Fujihata, Seigi Lee, Yutaka Miyawaki, Hirofumi Sugita, Hiroshi Sato, Keishi Yamashita

Gastric Cancer Original Article

Treatment efficacy of ramucirumab-containing chemotherapy in patients with alpha-fetoprotein producing gastric cancer

Daisaku Kamiimabeppu, Takeru Wakatsuki, Daisuke Takahari, Naoki Fukuda, Keitaro Shimozaki, Hiroki Osumi, Izuma Nakayama, Mariko Ogura, Akira Ooki, Eiji Shinozaki, Keisho Chin, Kensei Yamaguchi

Open Access Neutropenia Original Article

Aflibercept with FOLFIRI in Japanese patients with metastatic colorectal cancer: results of a post-marketing surveillance

Jun Watanabe, Tetsuji Terazawa, Shiho Yamane, Hirotaka Kazama, Hiroyuki Uetake, Takayuki Yoshino

Open Access Retinal Detachment Original Article

Encorafenib, binimetinib, and cetuximab in BRAF V600E–mutated colorectal cancer: an early post-marketing phase vigilance study

Hidenori Sakata, Maki Murase, Takeshi Kato, Kensei Yamaguchi, Kenichi Sugihara, Shigenobu Suzuki, Takayuki Yoshino

Original Article

Clinical outcomes following laparoscopic radical nephroureterectomy in octogenarians

Shigeki Koterazawa, Toru Kanno, Go Kobori, Katsuhiro Ito, Hiromichi Nakagawa, Toshifumi Takahashi, Naoto Takaoka, Shinya Somiya, Kanji Nagahama, Masaaki Ito, Yuzuru Megumi, Yoshihito Higashi, Seiji Moroi, Toshiya Akao, Hitoshi Yamada

Open Access Nausea Original Article

Veliparib with frontline chemotherapy and as maintenance in Japanese women with ovarian cancer: a subanalysis of efficacy, safety, and antiemetic use in the phase 3 VELIA trial

Mika Mizuno, Kimihiko Ito, Hidekatsu Nakai, Hidenori Kato, Shoji Kamiura, Kimio Ushijima, Shoji Nagao, Hirokuni Takano, Masao Okadome, Munetaka Takekuma, Hideki Tokunaga, Satoru Nagase, Daisuke Aoki, Robert L. Coleman, Yasuko Nishimura, Christine K. Ratajczak, Hideyuki Hashiba, Hao Xiong, Noriyuki Katsumata, Takayuki Enomoto, Aikou Okamoto

Laparoscopy Original Article

Survival after laparoscopic radical surgery for stage IA–IIB cervical cancer: 1316 consecutive cases from a national laparoscopic training center in China

Yuhui Huang, Jing Cai, Hongbo Wang, Weihong Dong, Yuan Zhang, Shaohai Wang, Xiaoqi He, Jianfeng Guo, Shouhua Yang, Zehua Wang

osteosarcoma Original Article

Secondary osteosarcoma: a challenge indeed

Cristina Meazza, Sironi Giovanna, Olga Nigro, Giovanna Gattuso, Barretta Francesco, Marta Podda, Roberto Luksch, Veronica Biassoni, Elisabetta Schiavello, Andrea Ferrari, Filippo Spreafico, Michela Casanova, Stefano Chiaravalli, Nadia Puma, Luca Bergamaschi, Virginia Livellara, Morosi Carlo, Antonina Parafioriti, Primo Daolio, Stefano Bastoni, Sabina Vennarini, Emilia Pecori, Ombretta Alessandro, Paola Collini, Maura Massimino, Monica Terenziani

Original Article

An adolescent and young adult (AYA) cancer education initiative aimed at healthcare students in Japan

Seido Takae, Ikkei Oyama, Mukyo Abe, Hideo Sugo, Yumari Kusano, Yoichiro Imaoka, Yuka Makino, Arisa Ukai, Yuko Mitsuyama, Chiaki Fujino, Rieka Miyamoto, Manami Yoshimura, Kaoru Yamada, Nao Suzuki

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine